- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 30.09. | Rovi acquires BMS facility in Phoenix as part of 5-year, $250M manufacturing deal | ||
| 29.09. | New CDMO on the bloc: Rezon Bio debuts with 2 plants to tackle biologics contract work in Europe | ||
| 29.09. | Novartis, Boehringer DTC platforms slash prices for Cosentyx, Spiriva Respimat | ||
| 29.09. | AstraZeneca, Daiichi's Enhertu shows early breast cancer prowess with another trial win, topping Roche's Kadcyla | ||
| 29.09. | Italian plasma specialist Kedrion reveals US investment plan after gaining FDA nod for Qivigy | ||
| 29.09. | Facing pricing pressure, PhRMA plans new website to highlight industry's direct purchasing programs | ||
| 29.09. | AstraZeneca plots US stock listing amid industry pullback from Britain | ||
| 29.09. | GSK's Emma Walmsely to step down as CEO in shock move, giving way to commercial lead Miels | ||
| 26.09. | Sanofi expands $35-per-month pricing to all insulin products | ||
| 26.09. | Trump administration teases MFN drug pricing rule as commitment deadline looms for companies | ||
| 26.09. | Trump's pharma tariffs arrive by way of Truth, offering 'relief' to many large drugmakers: analyst | ||
| 26.09. | AstraZeneca joins the DTC platform pack, offering up to 70% discounts on Farxiga, Airsupra | ||
| 26.09. | Amgen lays out $650M to grow Puerto Rico manufacturing campus, add hundreds of jobs | ||
| 26.09. | Fierce Pharma Asia-Celltrion's Lilly plant buy; Rexulti's PTSD snub; Glenmark, Hengrui's ADC deal | ||
| 26.09. | Asian generics powerhouse Lotus expands US presence with acquisition of Alvogen | ||
| 25.09. | Eli Lilly's oral SERD Inluriyo passes muster with FDA in breast cancer | ||
| 25.09. | Hansa eyes speedy FDA review after posting ph. 3 win for kidney transplant drug | ||
| 25.09. | With SCOTUS appeal, AstraZeneca makes last-gasp challenge against Medicare price negotiation program | ||
| 25.09. | BMS plots another DTC platform, this one offering Sotyktu at 80% discount to cash-pay patients | ||
| 25.09. | FDA takes close look at mifepristone REMS program after request from Republican AGs | ||
| 25.09. | Merck KGaA, grappling with geopolitical tensions, names new CEO | ||
| 25.09. | Moderna crowns new UK facility as other drugmakers pile on the kingdom | ||
| 25.09. | Guardant backs ALA's lung cancer testing awareness drive | ||
| 24.09. | Acadia grounds Prader-Willi candidate after trial failure, leaving the market to Soleno | ||
| 24.09. | Fujifilm Biotechnologies cuts ribbon on $3.2B antibody facility in NC |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .